Physician profile
Nancy L Ott
NPI 1295840783
$23,204.92
in general payments reported to CMS, 2019-2025
28 companies · $529 in 2025
The $529 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $78.28 · 2021: $230 · 2022: $4,279 · 2023: $7,813 · 2024: $9,836 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Consulting Fee: $1,500 · Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,275.00 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,403.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $19,755.13 | 2020-2025 | Nucala |
| Genentech USA, INC. | $1,515.66 | 2023-2024 | Xolair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.15 | 2019-2024 | Stiolto Respimat, Spiriva Respimat |
| Pharming Healthcare, INC. | $142.66 | 2019-2025 | Ruconest |
| Takeda Pharmaceuticals U.S.A., INC. | $142.24 | 2021-2025 | Cuvitru, Eohilia |
| Amgen INC. | $130.30 | 2021-2025 | Tezspire |
| Blueprint Medicines Corporation | $130.14 | 2023-2024 | Ayvakit |
| Csl Behring | $118.82 | 2021-2024 | Haegarda |
| Genzyme Corporation | $99.16 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $77.09 | 2019-2025 | Dupixent |
| Incyte Corporation | $76.93 | 2023-2024 | Opzelura |
| Astrazeneca Pharmaceuticals LP | $74.56 | 2021-2024 | Fasenra, Airsupra |
| Biocryst US Sales Co., LLC | $72.60 | 2021-2025 | Orladeyo |
| Phadia US INC. | $59.27 | 2023-2025 | Immunocap |
| Aimmune Therapeutics, INC. | $57.91 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cycle Pharmaceuticals INC | $46.06 | 2025 | Sajazir |
| Pfizer INC. | $37.22 | 2025 | |
| Leo Pharma INC. | $35.42 | 2024-2025 | Adbry |
| Teva Pharmaceuticals USA, INC. | $33.35 | 2019-2022 | |
| Axsome Therapeutics, INC. | $32.04 | 2025 | Symbravo |
| Abbvie INC. | $30.01 | 2025 | |
| Octapharma USA, INC. | $28.02 | 2025 | Octagam Immune Globulin (Human) |
| Novartis Pharmaceuticals Corporation | $23.06 | 2025 | |
| Merck Sharp & Dohme LLC | $19.84 | 2023 | |
| Verona Pharma, INC. | $19.46 | 2025 | Ohtuvayre |
| Alk-Abello, INC | $18.57 | 2021 | |
| Hologic Sales and Service, LLC | $17.46 | 2023 | Coolseal Generator |
| Optinose US, INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Ott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.